Suchergebnisse
Keurig Dr Pepper Q2 Earnings Approaching: Will It Surprise Investors?
Keurig Dr Pepper Inc. KDP is scheduled to release second-quarter 2026 results on Aug. 6, before market open. The company is expected to register bottom and top-line growth when it reports the
Is TripAdvisor (TRIP) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the
Fiserv is Set to Report Q2 Earnings: Here's What Investors Should Know
Fiserv, Inc. FISV is scheduled to release second-quarter 2026 results on Aug. 6, before market open.
FISV has outpaced the Zacks Consensus Estimate in three of the trailing four quarters and missed
REGN or INCY: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Regeneron (REGN) or Incyte (INCY). But which of these two stocks is more attractive to
Spire's Q3 Loss Wider Than Estimates, Revenues Decrease Y/Y
Spire Inc. SR reported a third-quarter fiscal 2026 adjusted loss of 26 cents per share, wider than the Zacks Consensus Estimate of a loss of 24 cents. The company reported adjusted earnings of 1
Should You Buy, Hold or Sell PRTH Stock Before Q2 Earnings?
Priority Technology Holdings PRTH is slated to release second-quarter 2026 results on Aug. 6, before market open. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings per share
Should Value Investors Buy Tutor Perini (TPC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the
Why Palantir Technologies (PLTR) Might be Well Poised for a Surge
Palantir Technologies Inc. (PLTR) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend
Can WMB's Momentum Deal Power 11% Growth Through 2030 and Beyond?
The Williams Companies, Inc. WMB is using its planned Momentum Midstream acquisition to deepen its Haynesville exposure and extend its Gulf Coast growth runway. The transaction is valued at up to
NANO Nuclear to Report Q3 Earnings: Buy, Hold or Sell the Stock?
NANO Nuclear Energy Inc. NNE is scheduled to release fiscal third-quarter results on Aug. 12, after market close. The Zacks Consensus Estimate is currently pegged at a loss of 28 cents per share
GE HealthCare Technologies (GEHC) Just Overtook the 200-Day Moving Average
GE HealthCare Technologies (GEHC) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, GEHC broke through the 200-day moving average
Target (TGT) Reports Next Week: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on higher revenues when Target (TGT) reports results for the quarter ended July 2026. While this widely-known consensus outlook is
SHG or EBKDY: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Banks - Foreign sector might want to consider either Shinhan Financial (SHG) or Erste Group Bank AG (EBKDY). But which of these two stocks is more attractive to
Is TTD Worth Buying as Cheap Valuation Clashes With Execution Risk?
The Trade Desk, Inc. TTD now trades at valuation levels far below its historical norms after a severe share-price decline. The apparent discount is striking, but it comes as revenue growth has
FFIV Beats Q3 Earnings Estimates on Systems Strength, Raises View
F5, Inc. FFIV delivered better-than-expected third-quarter fiscal 2026 results. The company reported third-quarter fiscal 2026 non-GAAP earnings of $4.73 per share, which increased 14% year over
The Baldwin Insurance Group (BWIN)'s Technical Outlook is Bright After Key Golden Cross
After reaching an important support level, Baldwin Insurance Group, Inc. (BWIN) could be a good stock pick from a technical perspective. BWIN recently experienced a "golden cross" event, which saw
IonQ Q2 2026 Earnings Tomorrow: Time to Buy Stock, Wait or Sell?
IonQ IONQ is scheduled to release its second-quarter 2026 results tomorrow, after market close, amid rapid strategic execution and expansion efforts. However, elevated valuation following the
Can MED's Trilivy Launch and Cost Cuts Drive a Q4 Profit Turnaround?
Medifast, Inc. MED is entering a decisive phase of its turnaround as the Trilivy metabolic-health platform rolls out alongside another round of cost reductions. Management expects progress toward




